Claybrook Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,592
Closed -$905K 150
2021
Q2
$905K Buy
+5,592
New +$905K 0.3% 87